Institutional Ownership
Hcw Biologics Inc
CUSIP 40423R204COM NEWHCWBQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
23.4%
Max % of class reported
Institutional Holders
13
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 17, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 35.9K | $12.9K |
| 2 | Citadel Advisors LLC | 26.1K | $9.4K |
| 3 | Tower Research Capital LLC (Trc) | 14.8K | $5.3K |
| 4 | Jane Street Group, LLC | 14.1K | $5.1K |
| 5 | Citigroup Inc | 10.5K | $3.8K |
| 6 | Golden State Wealth Management, LLC | 10.0K | $3.6K |
| 7 | Ubs Group AG | 9.2K | $3.3K |
| 8 | Wells Fargo & Company/Mn | 1.0K | $360 |
| 9 | Hrt Financial LP | 266.4K | $95 |
| 10 | Virtu Financial LLC | 47.8K | $17 |